Phase Biolabs
Phase Biolabs, based in Nottingham, UK, specializes in transforming waste CO2 into valuable chemicals and fuels through a revolutionary biotechnology process.
Services
Phase Biolabs specializes in transforming waste CO2 into additional revenue streams using revolutionary biotechnology. Their core service includes a gas fermentation process that converts hydrogen (H2) and carbon dioxide (CO2) emissions into valuable chemicals and fuels using patented microbes. This solution can retrofit existing setups and is compatible with any CO2 source. The company aims to upcycle 1 gigaton of CO2 by the year 2050, making a significant contribution to reducing carbon footprint.
Location and Facilities
Phase Biolabs is located at the Biodiscovery Institute, University of Nottingham, University Park, Nottingham, NG7 2RD, in Nottingham, England, United Kingdom. The company operates within the industrials sector, specifically focusing on climate and environmental solutions. Their presence is predominantly in the United Kingdom and Europe.
Industry Partnerships and Funding
Phase Biolabs has established partnerships and secured funding from notable organizations such as Breakthrough Energy, QTEC, SBRC, University of Birmingham, Science Entrepreneur Club, and Y Combinator. The company also receives support from Bill Gate's Breakthrough Energy Foundation through their Innovator Fellowship program. These partnerships and funding resources aid in advancing their innovative biotechnology solutions.
Career Opportunities
Phase Biolabs offers career opportunities that are listed on the Ashby platform. As an emerging leader in the biotechnological transformation of waste CO2, the company provides prospects for individuals interested in working within the industrials sector, particularly in the climate sub-sector. Their team, based at the Biodiscovery Institute, includes a dedicated group of professionals with a strong commitment to environmental sustainability.
Y Combinator and Development
Phase Biolabs is a participant of the Y Combinator W22 batch, reflecting their engagement with leading startup accelerators to further develop their technology and market presence. Their innovative approach to converting carbon emissions into valuable products positions them as a key player in climate-focused industrial biotechnology.